Shares of Amdocs Limited (NASDAQ:DOX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $101.20.
Several analysts recently commented on the stock. Oppenheimer raised their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. StockNews.com downgraded shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Thursday, November 14th. Barclays dropped their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research report on Thursday, November 14th. Finally, Stifel Nicolaus initiated coverage on shares of Amdocs in a report on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 target price on the stock.
Check Out Our Latest Report on Amdocs
Amdocs Trading Down 0.1 %
Shares of DOX traded down $0.12 during mid-day trading on Monday, reaching $87.18. The company had a trading volume of 645,746 shares, compared to its average volume of 678,937. The stock has a market cap of $10.25 billion, a price-to-earnings ratio of 20.66, a price-to-earnings-growth ratio of 1.45 and a beta of 0.72. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The firm has a fifty day simple moving average of $88.05 and a 200-day simple moving average of $84.55. Amdocs has a fifty-two week low of $74.41 and a fifty-two week high of $94.04.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.479 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.20%. Amdocs's dividend payout ratio (DPR) is currently 45.05%.
Institutional Investors Weigh In On Amdocs
Institutional investors have recently made changes to their positions in the business. Janus Henderson Group PLC raised its position in Amdocs by 1.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company's stock worth $579,632,000 after buying an additional 111,357 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock worth $556,700,000 after buying an additional 696,136 shares in the last quarter. LSV Asset Management raised its position in Amdocs by 7.9% during the second quarter. LSV Asset Management now owns 3,207,155 shares of the technology company's stock valued at $253,109,000 after purchasing an additional 234,096 shares during the period. Allspring Global Investments Holdings LLC lifted its position in Amdocs by 36.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company's stock worth $277,818,000 after buying an additional 851,022 shares during the last quarter. Finally, Brandes Investment Partners LP boosted its stake in shares of Amdocs by 31.1% during the 2nd quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company's stock worth $178,335,000 after purchasing an additional 536,359 shares during the period. Hedge funds and other institutional investors own 92.02% of the company's stock.
About Amdocs
(
Get Free ReportAmdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
